超声引导下经皮主动脉腔内手术入路部位失败术前风险评分
该回顾性研究纳入2014至2016年247例接受EVAR、FEVAR或TEVAR患者的469条股动脉,构建8分风险模型预测经皮入路失败(出血或血栓)。股动脉外壁直径、狭窄>50%及急诊手术为独立相关因素,模型C统计量0.89。入路失败需腹股沟切开,且与术后住院延长及入路相关再入院等增加相关。
要点
- 超声引导经皮入路在主动脉腔内手术中成功率达94%,双侧尝试者90%成功。
- 股动脉狭窄>50%、急诊手术及股动脉外壁直径较小是入路失败的独立相关因素。
- 基于上述因素的8分风险模型C统计量0.89,可辅助筛选高成功率患者。
核心结论
- 超声引导经皮入路在几乎所有主动脉腔内手术患者中可安全施行,但入路失败仍会发生,风险评分有助于患者选择与术后监测。
研究设计与样本
- 回顾性机构审查纳入2014至2016年连续接受EVAR、FEVAR或TEVAR的患者,排除经胸骨直接主动脉入路及医师改良支架者,共分析247例患者的469条股动脉。
主要发现
- 215例尝试双侧经皮入路患者中90%双侧成功,FEVAR双侧成功率78%低于EVAR的91%和TEVAR的94%(P = .03)。
- 股动脉外壁直径每增加1毫米,入路失败OR为0.003(0.0002-0.1),P < .001;股动脉狭窄>50%的OR为22.3(2.7-183.2),P < .01;急诊/紧急干预的OR为3.6(1.2-11.0),P = .03。
- 风险预测模型C统计量为0.89,Hosmer-Lemeshow拟合优度为0.99,Brier评分为0.04。
- 排除破裂动脉瘤治疗后,因入路失败切开或计划初始腹股沟切开者术后住院时间更长,入路相关再入院、重返手术室、腹股沟感染及心肌梗死发生率更高。
关键数值与推荐
- 8分风险模型C统计量0.89,Hosmer-Lemeshow拟合优度0.99,Brier评分0.04。
临床怎么用
- 可利用该风险评分筛选经皮入路成功可能性高的患者,并对高危患者加强闭合后股动脉 duplex 超声监测。
- 应向患者告知非计划腹股沟切开的风险,尤其是股动脉狭窄>50%或需急诊手术者。
局限性
- 本研究为单中心回顾性研究,样本来自2014至2016年,外推性需进一步验证。
- 计划初始腹股沟切开与失败后切开两组人数较少,统计效能不足以检测差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The factors associated with access site failure after ultrasound-guided percutaneous access for aortic endograft procedures remain poorly characterized. We developed a prediction model to risk stratify patients for access site failure. METHODS: We performed a retrospective institutional review of consecutive patients who underwent endovascular aneurysm repair (EVAR), fenestrated EVAR (FEVAR), or thoracic endovascular aortic repair (TEVAR) from 2014 to 2016. We excluded patients undergoing direct aortic access through sternotomy and patients treated with physician-modified endografts, given reporting restrictions. Our primary outcome was groin access site failure, which included bleeding and thrombosis. An 8-point risk model was created for access site failure using multivariable fractional polynomials and internally validated using bootstrapping. RESULTS: We identified 469 femoral arteries from 247 patients undergoing endovascular aortic repair procedures (EVAR, 75%; FEVAR, 8.0%; TEVAR, 17%). Surgeons performed percutaneous access in 97.2% of the femoral arteries, with 99.6% ultrasound use. Twenty-seven (5.9%) access site failures occurred (17 bleeding, 10 thrombosis), all treated with groin cutdown, for a successful percutaneous femoral artery access rate of 94%. Of the 215 patients with attempted bilateral percutaneous access, 90% had successful bilateral access. However, FEVAR had lower rates of successful bilateral access (FEVAR, 78%; EVAR, 91%; TEVAR, 94%; P = .03). Factors independently associated with percutaneous access site failure were femoral artery outer wall diameter (per millimeter increase: odds ratio [OR], 0.003 [0.0002-0.1]; P < .001), femoral artery stenosis >50% (OR, 22.3 [2.7-183.2]; P < .01), and urgent/emergent intervention (OR, 3.6 [1.2-11.0]; P = .03). A risk prediction model based on these criteria produced a C statistic of 0.89, a Hosmer-Lemeshow goodness of fit of 0.99, and a Brier score of 0.04. Excluding treatment for ruptured aneurysms, cutdown for access failure and planned initial groin cutdown resulted in longer postoperative lengths of stay and higher rates of access-related readmission, return to operating room, groin infection, and myocardial infarction compared with successful percutaneous access. There was no difference in major adverse events between planned initial groin cutdown and cutdown after failure; however, the small number of patients in these two comparison groups limits the statistical power to detect a difference. CONCLUSIONS: Percutaneous ultrasound-guided access can be safely performed in almost all patients undergoing endovascular aortic procedures, but access site failures do occur. This risk score can help users select patients with high likelihood of success, identify patients who need close scrutiny with postclosure femoral duplex ultrasound, and provide patient guidance about risk of unplanned groin cutdown.
引用
- Liang P, O'Donnell TFX, Swerdlow NJ, et al. Preoperative risk score for access site failure in ultrasound-guided percutaneous aortic procedures. J Vasc Surg. 2019. PMID: 30852039. doi:10.1016/j.jvs.2018.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。